Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant MelanomaMark R. Middleton, N. Thatcher, A. Coates et al.|Journal of Clinical Oncology|2000Cited by 1.3k